SeaStar Medical is trading 10% up at $3.61 after opening-market gains.
- No company-specific announcement dated August 10, 2026, has been identified.
- Investor attention may be supported by the August 11 acute kidney injury webinar and scheduled August 12 second-quarter results, but no direct causal link is confirmed.
- Healthcare stocks are stronger, providing additional sector support, though broader indexes are mixed.